ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted April 08, 2003

FDA Acts Against Potentially Risky Products Illegally Marketed as Street Drug Alternatives

On March 31, the Food and Drug Administration (FDA) announced enforcement actions against firms that are marketing street drug alternative products, some of which contain ephedra or other sources of ephedrine. FDA sent warning letters to eight firms because they marketed products that they claim can be used as alternatives to street drugs.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at www.consumerlab.com/join/